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ABSTRACT
Background Guidelines aim to reduce treatment variation
and improve quality of care. In the literature there is large
variation in the reported rates of adherence to recommen-
dations of surveillance for Barrett’s esophagus (BE). The aim
of this systematic review was to identify explanatory
parameters determining these differences in adherence
rates.
Methods Embase, Medline Epub, and Web of Science were
searched. Studies reporting adherence in at least one of five
domains were selected: general domain, surveillance inter-
val, biopsy protocol, landmark identification, and histopa-
thological information. Adherence was expressed as the
proportion of endoscopies or endoscopists being in accord-
ance with guideline recommendations. Variation in adher-
ence was evaluated by 1) meta-regression of adherence
rates in random effects meta-analysis to define subgroups,
and 2) compiling an overview of the most reported expla-
natory parameters for (non)adherence.
Results 56 studies, including 14002 BE patients and 4932
endoscopists, were included. Subgroup analysis showed
that variation in rates of adherences to surveillance interval
recommendations (I2 = 98%–99%) was explained by differ-
ence in country (43%), by practice type (90%), and by year
of publication (11%). Variation in adherence to the Seattle
protocol was explained by difference in country (14%). Fac-
tors most frequently reported to be associated with better
adherence were shorter BE length, salaried employment,
surveillance in university hospitals, and dedicated pro-
grams.
Conclusions This study provides insight into the variability
of rates of adherence to BE surveillance recommendations
between studies. Better adherence in university hospitals
and dedicated programs indicate that persistent alertness
of guidelines is important.
Original article
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Introduction
Barrett’s esophagus (BE) is a premalignant condition of esoph-
ageal adenocarcinoma (EAC), and is associated with gastro-
esophageal reflux disease. The incidence of EAC has been rising
over past decades. In the advanced stage, morbidity and mor-
tality of EAC are high, with a dismal prognosis [1]. Surveillance
was introduced to detect early signs of neoplastic progression.
Studies have shown repeatedly that BE patients participating in
a surveillance program had EAC detected at an earlier stage
compared with sporadic (symptomatic) EAC patients [2]. In ad-
dition to a better prospect of survival, early detection also of-
fers the possibility to apply minimally invasive treatment, such
as endoscopic eradication therapy, in selected cases. The gen-
erally accepted recommendation for patients with BE is to un-
dergo regular endoscopic follow-up with biopsies according to
the Seattle protocol.
In general, guidelines aim to reduce treatment variation and
improve quality of care [3–6]. Adherence to guideline recom-
mendations for surveillance of BE has been shown to be low,
with varying consequences [7]. In particular, if impaired cost-
effectiveness of surveillance due to shorter surveillance inter-
vals is accompanied by lower detection of dysplasia because of
nonadherence to the Seattle protocol and the Prague classifica-
tion, the healthcare burden of surveillance of BE patients is dis-
proportionate [8]. This may result in increased costs for society
and poorer detection of early neoplastic progression in BE pa-
tients [9].
The key question is, Why is the gap between guideline re-
commendations and practice patterns so substantial in studies?
As well as low rates of adherence to guideline recommenda-
tions, high adherence rates have also been reported [10]. Sour-
ces of this between-study variance are unclear. Explanatory fac-
tors for adherence may also explain this heterogeneity in ad-
herence rates between studies. Insight into the reason(s) be-
hind adherence may identify areas for improvement.
In this systematic review and meta-analysis we aimed to
identify explanatory parameters of (non)adherence by explor-
ing the sources of variation between studies and determining
risk factors for (non)adherence as reported in the literature.
Methods
This systematic literature review and meta-analysis was based
on the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) statement.
Search strategy
An electronic search in Embase, Medline Epub (Ovid), and Web
of Science was performed without restrictions in date or lan-
guage on 3 July 2017. The search strategy included the terms
relating to Barrett’s esophagus, adherence to the guideline,
and surveillance (see Table 1s in the online-only supplementary
material). Bibliographies of full-text articles assessed for elig-
ibility were handsearched.
Study selection
Five domains within BE surveillance were defined, based on
guidelines: general domain, surveillance interval, biopsy proto-
col, landmark identification, and histopathological information.
Within these domains, 19 single guideline recommendations
were selected (▶Table1). The recommended surveillance in-
terval, Seattle protocol, and Prague classification were assigned
as primary recommendations because of the expected impor-
tance in BE surveillance. Adherence to all of these recommen-
dations was estimated. To estimate adherence to the Prague
classification, only studies conducted after 2006 were includ-
ed, as this was the year of publication of this classification [11].
Studies reporting adherence to at least one of the 19 recom-
mendations were selected. Studies conducted in the setting of
a hospital, freestanding or open-access endoscopy center, or
based on the registry of members of a gastroenterological as-
sociation, were assessed for inclusion. Participants in these
studies had to be adults with known BE, with or without histo-
logical confirmation, who were enrolled in a surveillance pro-
gram, or endoscopists performing BE surveillance. No mini-
mum number of participants or duration of follow-up was set
for studies to be considered for inclusion. Types of studies eligi-
ble for this review were cross-sectional, retrospective, and pro-
spective cohort studies. Conference abstracts were included
only if the data were not published in peer-reviewed full-text
format.
Studies of patients who had already reached the end point of
high grade dysplasia, EAC, or who had undergone previous
endoscopic therapy were excluded. If studies only focused on
the effect of an intervention to improve adherence, such as a
dedicated surveillance program, they were included if baseline
data were available in the same or previously published article
or abstract.
Records identified by this search strategy were initially
screened, after deduplication, on title and abstract by one au-
thor (C.A.M.R.), and relevant full-text articles were then select-
ed. A second author (R.D.vdB) reviewed this process. In cases of
disagreement, a third independent author (M.C.W.S.) was con-
sulted. All reviewers were working in the field of gastroenterol-
ogy in both clinical practice and research. The deduplication
and management of records was performed using EndNote
X7.5 reference manager (Thomson Reuters).
Data extraction and synthesis
The extraction form used to collect the study data was based on
the Strengthening the Reporting of Observational studies in
Epidemiology (STROBE) statement.
The primary outcome was the variability between studies
explained by a specific subgroup, expressed as R2. This repre-
sents the variance in adherence rates, as explained for example
by difference in type of practice between studies, expressed as
a percentage. To be able to determine this between-study var-
iance, we extracted data concerning adherence to guideline re-
commendations in individual studies. We defined adherence as
a proportion of the number of adherent participants divided by
the total number of participants. As subjects could be either
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▶ Table 1 Guideline recommendations and associated patient, endoscopist, and facility variables, as scored for adherence in this systematic review
and meta-analysis.
Domain Recommendation in the guideline
General Performance of any form of surveillance
Total adherence to the guideline
Surveillance interval Surveillance interval in general*
Surveillance interval in patients without dysplasia (NDBE)*
Surveillance interval in patients with low grade dysplasia*
Biopsy protocol Seattle protocol*
Use of advanced imaging/high definition/high resolution white-light endoscopy
Landmark identification Report of indication of endoscopy
Report of level of squamocolumnar junction
Report of level of gastroesophageal junction
Report of level of diaphragm impression
Report of presence of hiatal hernia
Report of length of BE using Prague criteria*
Report of length of BE in general
Report of presence of inflammation
Report of presence of visible abnormalities
Histopathological information Report of presence of intestinal metaplasia
Report of presence of dysplasia
Review of second pathologist in cases of suspected dysplasia
Field of association Factors of potential association with adherence
Patient variables Age
Sex
Ethnicity
Length of BE
Endoscopist variables Age
Sex
Years in practice
Number of EGDs per week or month
Reimbursement
Belief in efficacy
Surgeon or physician
Awareness of the guideline
Agreement with the guideline
Facility variables Type of practice
Other Effect of intervention to improve adherence
NDBE, nondysplastic Barrett’s esophagus; BE, Barrett’s esophagus; EGD, esophagogastroduodenoscopy.
* Primary recommendations of the guideline.
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patients with BE in a study based on data retrieved from endos-
copy and pathology reports, or endoscopists in a question-
naire-based study, we referred to them as participants. If only
the practice pattern was reported (e. g. the number of endos-
copies with an interval of 3 years in nondysplastic patients,
rather than the number of adherent endoscopies), these results
were compared with the guideline as mentioned in the article.
If no guideline was mentioned, recommendations of the most
recently issued guideline at the time and location of that publi-
cation were used to determine the proportion of adherence
[3–5, 12–29]. In the United States, where multiple guidelines
exist, such cases (i. e. only the practice pattern was reported in
a study from the USA, but no guideline mentioned), the guide-
line of the American College of Gastroenterology was used.
The secondary outcome was to search for associations be-
tween adherence rates and explanatory parameters that had al-
ready been determined in the studies, with regard to patient,
endoscopist, or facility variables. The direction of the associa-
tion (increased or decreased probability of adherence), and
the presence or absence of its statistical significance, were ex-
tracted.
Quality assessment
Publication bias was assessed separately for each recommenda-
tion by funnel plots. In the process of methodological quality
assessment of the risk of bias in individual studies, another
tool was used for each outcome.
Because adherence to the guideline recommendations was
considered a proportion, the methodological quality of studies
was evaluated using the Loney Scoring Tool, adjusted to our
systematic review. Studies estimating prevalence or incidence
of a certain condition can be scored in this tool at a scale from
0 (worst score) to 8 (best score). A score of ≥5 was considered
good quality.
The quality of methods for associated factors was assessed
using the Quality In Prognosis Studies tool (QUIPS) [30]. Each
aspect could be scored as low, moderate, or high risk of bias.
Statistical analysis
In order to calculate between-study variance, first the propor-
tions of adherence of individual studies were pooled in a ran-
dom effects meta-analysis with a log odds transformation to
stabilize data. In cases where the proportion of adherence was
zero, a continuity correction was applied. This pooled estimate
and 95% confidence interval (CI) was interpreted as the propor-
tion of adherent participants. Heterogeneity was estimated
using Cochran’s test (Q statistic) and I2 statistic with a threshold
value of 25%, 50%, and 75% for low, moderate, and high,
respectively [31]. Only adherence reported as a proportion
with absolute numbers could be used in the meta-analysis.
Next, for primary recommendations (surveillance interval,
Seattle protocol, Prague classification), possible sources of het-
erogeneity were investigated in a subgroup analysis. We used
univariate meta-regression analysis. Prespecified variables that
were tested were year of publication and country; post hoc we
added type of practice and data collection (i. e. either self-re-
ported surveys or data retrieved from endoscopy and/or pa-
thology reports). In the subgroup type of practice, Veterans Af-
fairs medical facilities were considered as community hospitals,
and BE centers and teaching hospitals were considered as uni-
versity hospitals. The difference between subgroups was re-
ported as an odds ratio (OR). The variability between studies
explained by these subgroups was expressed using R2.
In addition to using the exploration of between-study var-
iance as a potential source of parameters explaining (non)ad-
herence, the associations between adherence rates and expla-
natory parameters that had already been determined in the in-
cluded studies were evaluated. Only those explanatory para-
meters that determined adherence rates to at least two pri-
mary recommendations (surveillance interval, Seattle protocol,
Prague classification) were plotted separately in a figure. Meta-
analysis was not possible because of the limited number of
studies per association. If statistical significance was not re-
ported in the studies, the chi-squared test with continuity cor-
rection was used where possible to calculate statistical signifi-
cance of the association.
Statistical calculations were done using R, version 3.4.1 (R
Foundation for Statistical Computing, Vienna, Austria; www.R-
project.org), using the metafor package for meta-analysis. P
values of <0.05 were considered statistically significant.
Sensitivity analysis
Outliers were identified based on a plot of influence diagnostics
outliers. Sensitivity analyses by excluding these studies showed
the difference compared with the original results. In addition,
the effect of excluding studies with a score of methodological
quality ≤5 was evaluated.
Results
Study selection and characteristics
Initially 684 records were identified. After deduplication, 475
were screened on title and abstract. Out of 86 articles assessed
for eligibility, 60 articles containing 56 studies were included
for qualitative and 49 articles containing 45 studies for quanti-
tative analyses. In some articles, the same study was conducted
with a different sample size, which explains the difference in
number of articles and studies included (▶Fig. 1).
The 56 studies (Table 2s) could be subdivided into four cate-
gories based on type of participants and methods used. In 19
cross-sectional studies, gastroenterologists and surgeons prac-
ticing surveillance were surveyed by a questionnaire to deter-
mine their practice patterns and factors influencing adherence.
In 26 retrospective cohort studies (17 single-center and nine
multicenter studies), endoscopy and pathology reports of BE
patients under surveillance were reviewed. In six prospective
studies, the effect of an intervention to improve adherence
rates was evaluated. The other five studies were a combination
of the previously mentioned, or other designs.
Of all studies included, the setting was reported as follows: 9
community hospitals and 16 university hospitals; 20 studies re-
ported data collection from a combination of these types of
centers, and in 11 studies the type of practice was unclear. The
earliest study was published in 1997, the most recent in 2017.
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The geographical setting was developed countries in all studies:
Argentina, Australia, several countries in Europe, and North
America. A total of 14 002 BE patients were included, with a
median sample size of 210 (interquartile range [IQR] 103–
367), and 4932 endoscopists participated, with a median sam-
ple size of 203 (IQR 123–260).
Data from the original papers were not included in the anal-
ysis in cases of: 1) lack of report of numbers, results were only
described in words (four studies) [supplementary references
47, 50, 73, 97]; 2) report of mean surveillance interval, mean
number of biopsies, or mean biopsy percentage, instead of pro-
portions (eight studies) [supplementary references 42, 51, 54,
58, 70 ,84, 87, 96]; 3) separate reporting of adherence to four-
quadrant biopsies and biopsies every 2 cm (three studies) [sup-
plementary references 58, 60, 67]; and 4) separate reporting of
adherence in participating centers (one study) [supplementary
reference 50].
Subgroups explaining between-study variance
Pooled proportions of adherence ranged from 18% to 89%
(▶Fig. 2). For recommendations with pooled estimates based
on≥20 studies, forest plots were constructed (▶Fig. 3, Fig. 1s,
Fig. 2s). Adherence to surveillance interval was 55% for nondys-
plastic Barrett’s esophagus (NDBE) (95%CI 44%–66%), 50% for
low grade dysplasia (LGD) (95%CI 38%–62%), and 49% to the
Seattle protocol (95%CI 36–62%). In Table3s, the details of
other pooled estimates are shown.
In addition to providing information concerning the propor-
tion of adherence, which was pooled in the meta-analysis, sev-
eral studies also showed whether intervals were too short or
too long. For the recommendation “interval NDBE,” 13 studies
reported an interval that was too short [supplementary refer-
ences 41, 47, 51, 53, 60, 62, 67, 70, 77, 78, 90, 91, 95], and only
one study reported an interval that was too long among the
nonadherent participants [supplementary reference 56]; one
study reported an equal proportion of endoscopies with sur-
veillance intervals that were too short or too long [supplemen-
tary reference 74]. For “interval LGD,” 12 studies reported an
interval that was too short [supplementary references 41, 47,
53, 60, 62, 67, 75, 77, 88, 90, 91, 95], and in four studies the in-
terval was too long [supplementary references 70, 56, 74, 78].
For the recommendation “Seattle protocol,” 12 studies report-
ed that fewer biopsies than expected were taken [supplemen-
tary references 42, 54, 56, 58, 70, 73–75, 84, 91, 95, 96], and
one study reported a surplus [supplementary reference 77].
Heterogeneity was high (≥75%) for all pooled estimates. For
“surveillance interval general,” 90% of heterogeneity could be
explained by difference in type of practice between studies
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Records identified through database searching
▪Embase.com 412
▪Medline Epub (Ovid) 111
▪Web of Science 161
(n = 684)
Additional records 
identified through 
other sources
(n = 9)
Records after duplicates removed
(n = 475)
Records screened
(n = 475)
Records excluded
(n = 389)
Full-text articles assessed for eligibility
(n = 86)
60 articles containing
56 studies included in qualitative analysis
49 articles containing 
45 studies included in quantitative synthesis
(meta-analysis)
Full-text articles excluded (n = 26)
▪Comment on other study (9)
▪Focus on effectiveness of surveillance (6)
▪Update of guideline (3)
▪Qualitative study of adherence (3)
▪Focus on associated factors (1)
▪Interview expert (1)
▪Inconsistencies (1)
▪Only effect intervention available (1)
▪Data not in accordance with our aim (1) 
▶ Fig. 1 Study flow diagram.
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and 11% by year of publication (▶Table 2). For “interval NDBE,”
43% could be explained by differences in country. For “Seattle
protocol,” 14% of the between-study variance was explained by
differences in country. And for the “Prague classification,” 12%
of heterogeneity was due to differences in data collection.
Factors associated with surveillance guideline
adherence
An overview was compiled of reported factors that influence
adherence to primary recommendations of the surveillance
guideline (▶Fig. 4). The following factors were reported most
frequently to be associated with better adherence: shorter BE
segments (Seattle protocol); salaried employment instead of
productivity-based employment of the endoscopists (surveil-
lance intervals); university hospitals (Seattle protocol and Pra-
gue classification); the introduction of dedicated surveillance
programs, often reported as “interventions” (surveillance inter-
vals, Seattle protocol, and Prague classification). The type of in-
terventions reported to improve adherence were participation
in a trial, pooling patients on a dedicated list, and formalized
and multifaceted intervention programs. Only the implementa-
tion and dissemination of guidelines were not reported as often
to improve adherence to guideline recommendations. Other
factors less frequently reported to be associated with better ad-
herence to guideline recommendations were more belief in the
efficacy of surveillance, and awareness and agreement of the
endoscopists with the guideline (surveillance interval), younger
age of the endoscopists (surveillance interval and Seattle pro-
tocol), and physicians compared with surgeons (Prague crite-
ria). Only 10 out of 29 studies performed multivariable analysis
to identify factors associated with better adherence.
Quality assessment
Methodological quality concerning the between-study variance
was good for 34 studies (scored≥5, Table 4s), while 15 scored <
5. Biased data collection using self-reported surveys, inade-
quate response rate, and a lack of adequate description of par-
ticipants led to reduced quality scores most frequently. Studies
with a low score on aspect 5 of the Loney Scoring tool also
scored low on aspect 4 of the QUIPS (Table 5s) within the con-
text of the methodological quality of the secondary objective.
The maximum score was low for 1 study, medium for 14 stud-
ies, and high for 15 studies. Reduced quality was often attribu-
table to the lack of correction for confounders and self-report-
ed outcome measurement. Funnel plots were rather symmet-
ric, providing no evidence of publication bias (Fig. 3s).
Sensitivity analysis
The exclusion of outliers or low quality studies showed similar
results in assessing adherence rates. The results of sensitivity
analyses of adherence to guideline recommendations are
shown in Table6s.
Domain
General
Surveillance interval
Biopsy protocol
Landmark identification
Histopathological information
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▶ Fig. 2 Summary of pooled proportions and 95% confidence intervals of adherence to guideline recommendations, subdivided per domain. n,
number of studies included in the meta-analysis; BE, Barrett’s esophagus; GE, gastroesophageal; IM, intestinal metaplasia; LGD, low grade dys-
plasia; NDBE, nondysplastic Barrett’s esophagus; SQ, squamocolumnar.
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Discussion
In this systematic review and meta-analysis, we pooled the
overall worldwide rates of adherence to guideline recommen-
dations as researched in the literature, which showed a large
variance between studies. Difference in country and type of
practice were the main contributing factors for the large het-
erogeneity in pooled estimates. Although many studies aimed
to identify explanatory parameters for nonadherence, most of
them were observed in univariate analysis in a retrospective co-
hort design. The graphical representation of this study shows
that factors most frequently reported to be associated with
better adherence were shorter BE length, salaried employment,
surveillance in university hospitals, and dedicated surveillance
programs. We performed our research according to estab-
lished guidelines for systematic reviews and did a thorough
meta-analysis. Because results from multiple studies were
combined, this study provides insight into the variability be-
tween studies, rather than adherence rates of single studies.
In line with the subgroup analysis, surveillance was reported
to be more often in line with guideline recommendations in
university hospitals than in general hospitals. In addition, bet-
ter adherence was observed in dedicated programs. This indi-
cates that persistent alertness of guidelines is important. We
found that interventions such as a dedicated nurse and other
formalized surveillance programs improved adherence, and
that the effect of only implementing a guideline is limited. It is
known that more than 1 year after a guideline has been imple-
mented, clinicians’ adherence to it declines [32]. Simply being
aware of the guideline was not often contributing to adherence
in our review; however, younger gastroenterologists, who had
been trained more recently, were more adherent to the use of
the Prague criteria. University hospitals, with their emphasis on
teaching and research, were also associated with better adher-
ence.
Remarkably, we found that more intensive surveillance was
recommended if there was more belief in the efficacy of surveil-
lance, and that more agreement with the guideline was related
to better adherence to the surveillance interval. Similar findings
have been reported for adherence to guidelines in other spe-
cialties [33]. Furthermore, the evidence behind the Barrett’s
surveillance guideline recommendations is moderate at best.
Therefore, to improve adherence, the evidence underpinning
Author and year Adherent Total Prevalence ratio [95% CI]
Abrams 2009 1149 2245 0.51 [0.49, 0.53]
Ackroyd 2007 38 58 0.66 [0.53, 0.77]
Amamra 2007 116 200 0.58 [0.51, 0.65]
Arastu 2016 61 125 0.49 [0.40, 0.58]
Cameron 2014 14 69 0.20 [0.12, 0.31]
Curvers 2007 229 289 0.79 [0.74, 0.84]
Das 2008 104 217 0.48 [0.41, 0.55]
Farfus 2013 64 93 0.69 [0.59, 0.77]
Ge 2016 81 167 0.49 [0.41, 0.56]
Ghuman 2015 116 367 0.32 [0.27, 0.37]
Gordon-Cooke 2015 32 91 0.35 [0.26, 0.45]
Krishnan 2010 459 504 0.91 [0.88, 0.93]
MacNeil 2003 69 151 0.46 [0.38, 0.54]
Mandal 2003 64 155 0.41 [0.34, 0.49]
Manjunath 2009 39 86 0.45 [0.35, 0.56]
Menezes 2015 413 417 0.99 [0.97, 0.99]
Moss 2003 14 54 0.26 [0.16, 0.39]
Ooi 2017 56 587 0.10 [0.07, 0.12]
Phillpotts 2016 20 34 0.59 [0.42, 0.74]
Ramnath 2004 55 235 0.23 [0.18, 0.29]
Shen 2003 11 44 0.25 [0.14, 0.40]
Shi 2016 148 204 0.73 [0.66, 0.78]
Smith 1999 9 106 0.08 [0.06, 0.16]
Van Sandick 2000 123 237 0.52 [0.46, 0.58]
Walker 2014 33 125 0.26 [0.19, 0.35]
RE model (Q = 944.90, df = 24, P = 0.00; I2= 98.8 %) 0.49 [0.36, 0.62]
0.06 0.25 0.5
Proportion of adherence (logit scale)
0.75 0.99
▶ Fig. 3 Forest plot of pooled proportion of adherence to guideline recommendation “Seattle protocol.” CI, confidence interval; RE, random
effect.
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the guidelines should be strengthened, for example by im-
provement of risk stratification.
In this systematic review, pooled estimates showed large
heterogeneity, as expected. To evaluate the influence of meth-
odological differences of studies, rather than, for example, type
of practice, we also estimated whether the data could be influ-
enced by self-reported data collection [34]. This explained only
a small proportion of the heterogeneity in the subgroup analy-
sis. However, as the heterogeneity between studies addressing
adherence to Prague classification could be explained by >10%
by differences in data collection, results should be interpreted
with caution. We also estimated the influence of the year of
publication. In other words, we evaluated whether the year of
publication could explain heterogeneity, and if adherence im-
proves or declines over time. For surveillance interval in gener-
al, > 10% of heterogeneity could be explained by the year of
publication. Although the results per year category are not sta-
tistically significant, increasing ORs for categories of more re-
cent publications may indicate improving adherence over the
years.
To our knowledge, this is the first study to provide the
pooled estimates of adherence to guideline recommendations
of BE surveillance. The findings of this study stress the rele-
vance of improving the adherence of BE surveillance for two
reasons. First, poor adherence to the Seattle protocol could in-
crease the health care burden. Although there is no conclusive
evidence available, the Seattle protocol has been shown to re-
duce sampling error with improved detection of dysplasia,
compared with random biopsies [35]. Alternatively, nonadher-
ence reduces the likelihood of detecting dysplasia. In a previous
study with a cohort of 2245 BE patients under surveillance, the
detection was reduced by almost half in cases of nonadherence
to the biopsy protocol [7]. Consequently, because of nonadher-
ence, EAC may be detected at a later stage, with a negative in-
fluence on the outcome for BE patients. However, missed dys-
plasia in a repeat endoscopy within 24 months was not associat-
ed with adherence to the Seattle protocol [36]. The detection of
dysplasia was influenced not only by adherence to the biopsy
protocol, but adherence to reporting the length of the BE seg-
ment using the Prague classification was also associated with
better detection of dysplasia [37].
Second, performing surveillance endoscopies at an earlier
time point than that recommended in the guideline increases
the total number of surveillance endoscopies performed. The
cost-effectiveness of the current surveillance strategies, as re-
commended by guidelines, is under discussion; there is dis-
agreement about the optimal surveillance interval. However,
three studies suggested this interval should not be less than 3
years for NDBE and not less than 1 year for LGD [9, 38]. The re-
sults of these studies indicate that a shorter interval than re-
commended by the current guidelines would increase the
health care costs even more. Only one study reported cost-ef-
fectiveness with shorter intervals [39].
Consequently, if impaired cost-effectiveness of surveillance
due to shorter surveillance intervals is accompanied by lower
detection of dysplasia because of nonadherence to the Seattle
protocol and the Prague classification, the health care burden
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of surveillance of BE patients is disproportionate. This results in
exorbitant costs for society and poorer detection of early neo-
plastic progression in BE patients.
This study has several strengths and limitations. We con-
ducted this systematic review and meta-analysis according to
standardized protocols. Additional analysis for between-study
variation provided insight into data and heterogeneity of re-
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▶ Fig. 4 Overview of association between primary recommendations of adherence to the guideline (top horizontal pane) and explanatory
parameters (right vertical pane). The x-axis (adherence) represents whether studies were associated with adherence (“yes”), not associated with
adherence (“no”), no difference between groups (“ind”, if the absolute proportions of each group were not mentioned in the study, only that
there was no difference). These results could be significant (black, “s”), or nonsignificant (grey, “ns”). The y-axis represents number of studies
that reported the associations as mentioned in the graph. Results of multivariate analysis were used if available. ACG, American College of Gas-
troenterology; BE, Barrett’s esophagus; EGD, esophagogastroduodenoscopy; LGD, low grade dysplasia; LSBE, long-segment Barrett’s esopha-
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sults. The methodological quality of some included studies was
limited, with data collection based on self-report as a contribut-
ing factor in over one-third of articles. As all studies on adher-
ence have been conducted in highly developed countries, cau-
tion should be exercised with regard to the generalizability of
the results. An important limitation with a potentially large
contribution to the results is that parameters associated with
adherence were identified in most studies in univariate analy-
sis, whereas other confounders could be important as well.
In conclusion, adherence to BE surveillance guidelines is sub-
optimal, thereby adversely affecting health care burden (e. g.
impaired detection of dysplasia and superfluous costs). Oppor-
tunities for improving adherence should be further investiga-
ted, preferably without self-reported surveys and with adjust-
ment for confounding factors. Attention should be paid to in-
crease the evidence for guideline recommendations. Short-
term meaningful consequences include optimal introduction
and monitoring of formalized surveillance programs.
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